NVS rises premarket on positive multiple sclerosis trial readout
NVS is up in premarket trading following a positive clinical trial readout for its multiple sclerosis drug.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.